Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Actuate Therapeutics Inc | 9,893,651 | 9,965,079 | +71,428 | $66.98M | $60.89M | 83.89% | -$6.09M |
| Opus Genetics, Inc.(IRD) | 995,249 | 3,683,429 | +2,688,180 | $977.1K | $3.46M | 4.77% | +$2.49M |
| Lantern Pharma Inc.(LTRN) | 1,207,709 | 1,075,952 | -131,757 | $4.28M | $3.40M | 4.68% | -$875.3K |
| Rein Therapeutics Inc.(RNTX) | 1,690,751 | 1,690,751 | 0 | $2.99M | $2.37M | 3.26% | -$625.6K |
| Cognition Therapeutics, Inc.(CGTX) | 6,000,000 | 6,000,000 | 0 | $2.52M | $1.86M | 2.56% | -$664.8K |
| In8bio Inc | 8,600,001 | 286,664 | -8,313,337 | $1.43M | $599.1K | 0.83% | -$828.5K |